Regulatory Guidance Monthly Review - July 2020
July 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory...
Posts about
Clinical Trial Regulations (11)
Regulatory Guidance Monthly Review - June 2020
June 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory...
Regulatory Guidance Monthly Review - May 2020
MAY 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory...
EMA Guidance on Management of Clinical Trials during COVID-19 Pandemic
Summary of Key Considerations Outlined in the Third Edition of the EMA Guidance
The European...
Clinical Trial Conduct During COVID-19 Pandemic Response
Key Lessons Learned during the First Month of the COVID-19 Pandemic Response
As we are well-rooted...
Regulatory Guidance Monthly Review - April 2020
April 2020
Each month, Veristat's regulatory team tracks and shares a selection of new...
Regulatory Guidance Monthly Review - March 2020
March 2020
Each month, Veristat's regulatory team tracks and shares a selection of new...
MRHA Guidance for Clinical Trials During COVID-19 Outbreak
MHRA Guidance On Clinical Trial Conduct During COVID-19 Pandemic
Regulatory Insights on COVID-19 Updates From FDA | 31 March 2020
FDA UPDATES - For Sponsors with Products Intended to Treat Indications Other than COVID-19
In...